Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

331 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma.
Hadoux J, Malka D, Planchard D, Scoazec JY, Caramella C, Guigay J, Boige V, Leboulleux S, Burtin P, Berdelou A, Loriot Y, Duvillard P, Chougnet CN, Déandréis D, Schlumberger M, Borget I, Ducreux M, Baudin E. Hadoux J, et al. Among authors: duvillard p. Endocr Relat Cancer. 2015 Jun;22(3):289-98. doi: 10.1530/ERC-15-0075. Epub 2015 Mar 13. Endocr Relat Cancer. 2015. PMID: 25770151
Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma.
Durante C, Boukheris H, Dromain C, Duvillard P, Leboulleux S, Elias D, de Baere T, Malka D, Lumbroso J, Guigay J, Schlumberger M, Ducreux M, Baudin E. Durante C, et al. Among authors: duvillard p. Endocr Relat Cancer. 2009 Jun;16(2):585-97. doi: 10.1677/ERC-08-0301. Epub 2009 Feb 24. Endocr Relat Cancer. 2009. PMID: 19240182 Clinical Trial.
Frequency and characterization of gastro-entero-pancreatic neuroendocrine tumor patients with high-grade of uptake at somatostatin receptor scintigraphy.
Chougnet CN, Leboulleux S, Caramella C, Lumbroso J, Borget I, Déandreis D, Duvillard P, Elias D, de Baere T, Vélayoudom-Céphise FL, Guigay J, Ducreux M, Schlumberger M, Baudin E. Chougnet CN, et al. Among authors: duvillard p. Endocr Relat Cancer. 2013 Mar 22;20(2):229-39. doi: 10.1530/ERC-12-0169. Print 2013 Apr. Endocr Relat Cancer. 2013. PMID: 23404855
Are G3 ENETS neuroendocrine neoplasms heterogeneous?
Vélayoudom-Céphise FL, Duvillard P, Foucan L, Hadoux J, Chougnet CN, Leboulleux S, Malka D, Guigay J, Goere D, Debaere T, Caramella C, Schlumberger M, Planchard D, Elias D, Ducreux M, Scoazec JY, Baudin E. Vélayoudom-Céphise FL, et al. Among authors: duvillard p. Endocr Relat Cancer. 2013 Aug 19;20(5):649-57. doi: 10.1530/ERC-13-0027. Print 2013 Oct. Endocr Relat Cancer. 2013. PMID: 23845449
Post-Radiation Grade 3 Neuroendocrine Carcinoma: A New Entity?
Hadoux J, Blanchard P, Scoazec JY, Burtin P, Planchard D, Malka D, Berdelou A, Boige V, Duvillard P, Leboulleux S, Faron M, Tselikas L, Deutsch E, Ducreux M, Baudin E. Hadoux J, et al. Among authors: duvillard p. Neuroendocrinology. 2021;111(1-2):139-145. doi: 10.1159/000504255. Epub 2019 Oct 22. Neuroendocrinology. 2021. PMID: 31639792
[Management of metastatic neuroendocrine tumors].
Baudin E, Guigay J, Ducreux M, Duvillard P. Baudin E, et al. Among authors: duvillard p. Ann Pathol. 2011 Nov;31(5 Suppl):S85-6. doi: 10.1016/j.annpat.2011.08.016. Epub 2011 Sep 21. Ann Pathol. 2011. PMID: 22054472 French. No abstract available.
331 results